Black Diamond Therapeutics, Inc. ( BDTX) - Stock Earnings
BDTX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
BDTX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -15.1 million USD | — USD |
| 2026Q1 | -9.0 million USD | — USD |
| 2026Q2 | -9.9 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BDTX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -82.4 million USD | — USD |
| 2024 | -69.7 million USD | — USD |
| 2025 | 22.4 million USD | 70.0 million USD |
| 2026 Est. | — | — |
BDTX
Price: $1.82
52 week price:
Earnings Per Share: -0.75 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 81500
Market Capitalization: 108.3 million